Fineline Cube

Follow:
14473 Articles
Policy / Regulatory

Fujian’s Fourth Round VBP Seeks Public Feedback on Drug Procurement List

CompanyDrug

FDA Approves Pfizer’s Braftovi + Mektovi Combo for BRAF V600E Metastatic NSCLC

Policy / Regulatory

China Introduces Trial Measures for Science and Technology Ethics Review

CompanyDrug

Roche’s Ocrevus Demonstrates Long-Term Efficacy in Multiple Sclerosis Treatment

Policy / Regulatory

China Releases First Supplement to 2020 Pharmacopoeia with 47 New Drug Varieties

CompanyDrug

Sichuan Huiyu Pharmaceutical’s HYP2090PTSA Gains NMPA Approval for KRAS G12C Solid Tumors

CompanyDeals

Livzon Pharmaceutical Secures Licensing Agreement for LanssonPharm’s PDE4 Inhibitor in China

CompanyDrug

AbbVie’s Rinvoq Demonstrates Sustained Efficacy in Late-Stage Atopic Dermatitis Study

Policy / Regulatory

China’s Healthcare Landscape: Key Insights from the 2022 Statistical Communique

CompanyDrug

Lee’s Pharmaceutical’s Subsidiary Announces Positive Results for Myopia Treatment NVK002

CompanyDrug

J&J’s Cetrelimab and TAR-200 Gain Tacit Approvals for Bladder Cancer Trials

CompanyMedical Device

Nanjing Geneseeq’s NSCLC TMB Detection Kit Approved by NMPA